If you’re considering different choices for losing weight, there’s now an encouraging new option that’ll be available soon and could much an enormous difference. The meals and Drug Administration (FDA) just announced its approval of the drug called Wegovy, and it might be totally life-changing.

In fact, it’s the very first chronic weight loss medication that the agency has approved in seven years, and there’s grounds why scientists and health experts alike are extremely looking forward to what it could do.

What is Wegovy?

Wegovy is a higher dosage of the popular diabetes medication called semaglutide. Research has revealed that the compounds inside it come with an appetite-suppressing, which leaves people feeling fuller after eating less food. In turn, this helps them slim down with time.

Just how effective is Wegovy? In clinical trials, participants lost an average of 12.4 percent of the initial bodyweight, and much more incredibly, they saw consistent weight loss for approximately 16 months with no plateau.

People who have diabetes type 2 and are obese may also see dual health advantages, because the drug might help them regulate their blood sugar levels while also managing their weight.

What would be the negative effects?